Achieving symptom relief in patients with myalgic encephalomyelitis by targeting the neuro-immune interface and optimizing disease tolerance
Rodriguez L, Pou C, Lakshmikanth T, Zhang J, Mugabo CH, Wang J, Mikes J, Olin A, Chen Y, Rorbach J, et al.
Oxford Open Immunology · 2023
Key finding
By performing longitudinal, systems-level monitoring of the blood immune system in these patients, we uncover signs of chronic immune activation in ME, as well as immunological correlates of improvement that center around gut-homing immune cells and reduced inflammation.
- Condition
- Chronic Fatigue Syndrome
- Stimulation
- taVNS
- Evidence tier
- Controlled Clinical Trial
- Participants
- —
Cite this study
Rodriguez, L., Pou, C., Lakshmikanth, T., Zhang, J., Mugabo, C. H., Wang, J., Mikes, J., Olin, A., Chen, Y., Rorbach, J., Juto, J. E., Li, T. Q., Julin, P., & Brodin, P. (2023). Achieving symptom relief in patients with myalgic encephalomyelitis by targeting the neuro-immune interface and optimizing disease tolerance. Oxford Open Immunology, 4(1). https://doi.org/10.1093/oxfimm/iqad003
Related studies in Chronic Fatigue Syndrome
Potential application of brain-gut axis-based treatments in Long COVID and ME/CFS: a case-based systematic review
Kim et al. · Journal of translational medicine · 2026 · Systematic Review / Meta-Analysis
Complementary and alternative medicine for long COVID: a systematic review of randomized controlled trials
Yang et al. · Therapeutic advances in chronic disease · 2023 · Systematic Review / Meta-Analysis
Evidence of bottom-up homeostatic modulation induced taVNS during emotional and Go/No-Go tasks
Camargo et al. · Experimental brain research · 2024 · Randomised Controlled Trial
The effects of non-invasive vagus nerve stimulation on fatigue in participants with primary Sjogren's syndrome
Tarn et al. · Neuromodulation · 2023 · Randomised Controlled Trial
Summary by Vagus Research. Always consult the primary source for the authoritative record.